Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TCF7 promotes a mammary cancer-stem-like phenotype leading to metastasis via potentiation of a hybrid epithelial/mesenchymal (E/M) phenotype
    Meeting Abstract

    Liang, H.; Benard, O.; Ren, Z.; Suyama, K.; Norton, L.; Hazan, R. B.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response
    Meeting Abstract

    Rosen, M.; Amar, D.; Winters, I.; Rizvi, H.; Nie, W.; Wall, G.; Petrov, D.; Winslow, M.; Rudin, C.; Juan, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterization of genomic diversity in high grade serous ovarian and triple negative breast cancer at single cell resolution
    Meeting Abstract

    Williams, M. J.; Funnell, T.; O'Flanagan, C. H.; McPherson, A.; Aparicio, S.; Shah, S. P.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Examining the impact of chromosomal instability on mucosal melanoma tumor infiltrate and responses to PD-1 based therapy
    Meeting Abstract

    Armstrong, E.; Gottesdiener, L.; Schultz, N.; Bakhoum, S. F.; Hollmann, T. J.; Shoushtari, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The role of EGFR in resistance to tucatinib and its therapeutic implications
    Meeting Abstract

    Veeraraghavan, J.; Liao, F. T.; Gordon, T.; Selenica, P.; Nanda, S.; Qin, L.; Zhu, Y.; Patel, J. A.; Gazzo, A.; Stossi, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Case study of single-cell protein activity-based drug prediction and validation for precision treatment of cholangiocarcinoma
    Meeting Abstract

    Tomassoni, L.; Obradovic, A.; Dela Cruz, F.; Yu, D.; Fraser, E.; Bates, S. E.; Saenger, Y.; Califano, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromosomal instability as a mediator of anti-tumor immunity in pancreatic cancer
    Meeting Abstract

    Bronder, D.; Sriram, R. K.; Bakhoum, S. F.
    Cancer Research (2022)

    Fulltext@MSK | Save